Rachel Royfman

601 total citations
20 papers, 365 citations indexed

About

Rachel Royfman is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Rachel Royfman has authored 20 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 5 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Rachel Royfman's work include Cardiac Valve Diseases and Treatments (3 papers), Infective Endocarditis Diagnosis and Management (3 papers) and PARP inhibition in cancer therapy (3 papers). Rachel Royfman is often cited by papers focused on Cardiac Valve Diseases and Treatments (3 papers), Infective Endocarditis Diagnosis and Management (3 papers) and PARP inhibition in cancer therapy (3 papers). Rachel Royfman collaborates with scholars based in United States and Canada. Rachel Royfman's co-authors include Tomer Avidor‐Reiss, Kathryn Smedlund, Ritu Chakravarti, Ahmed A. Abokor, Emily Fishman, Usman Ashraf, Lauren G. Koch, Ana Maria Trindade Grégio, Laura Stanbery and John Nemunaitis and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Rachel Royfman

18 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rachel Royfman United States 8 108 96 82 78 57 20 365
Nathalie Da Silva France 10 155 1.4× 56 0.6× 47 0.6× 44 0.6× 58 1.0× 21 320
Kyra Minahan Australia 9 161 1.5× 24 0.3× 65 0.8× 24 0.3× 46 0.8× 11 322
Mira Mousa United Arab Emirates 11 132 1.2× 39 0.4× 23 0.3× 107 1.4× 23 0.4× 20 366
Andrea Mathe Australia 12 389 3.6× 92 1.0× 50 0.6× 31 0.4× 56 1.0× 16 704
Songyang Yuan United States 10 111 1.0× 42 0.4× 22 0.3× 15 0.2× 89 1.6× 17 475
Ruiqin Han China 14 187 1.7× 73 0.8× 42 0.5× 36 0.5× 17 0.3× 31 479
Tiantian Li China 11 127 1.2× 27 0.3× 39 0.5× 32 0.4× 17 0.3× 26 339
Amal F. Alshammary Saudi Arabia 10 103 1.0× 16 0.2× 24 0.3× 33 0.4× 31 0.5× 36 281
Yile Zhang China 11 77 0.7× 123 1.3× 134 1.6× 13 0.2× 15 0.3× 42 331

Countries citing papers authored by Rachel Royfman

Since Specialization
Citations

This map shows the geographic impact of Rachel Royfman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Royfman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Royfman more than expected).

Fields of papers citing papers by Rachel Royfman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Royfman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Royfman. The network helps show where Rachel Royfman may publish in the future.

Co-authorship network of co-authors of Rachel Royfman

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Royfman. A scholar is included among the top collaborators of Rachel Royfman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Royfman. Rachel Royfman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Royfman, Rachel, et al.. (2025). Extrahepatic and Circulating miR-122: Diagnostic Implications and Future Directions. MicroRNA. 14(2). 93–100.
2.
Abdel‐Rasoul, Mahmoud, et al.. (2025). ELEVATED RISK OF CARDIOVASCULAR EVENTS IN PATIENTS RECEIVING LENVATINIB ANTICANCER THERAPY. Journal of the American College of Cardiology. 85(12). 2511–2511.
3.
Morand, Susan, Rachel Royfman, Aditi Singh, et al.. (2024). Targeted Combination of Poly(ADP-ribose) Polymerase Inhibitors and Immune Checkpoint Inhibitors Lacking Evidence of Benefit: Focus in Ovarian Cancer. International Journal of Molecular Sciences. 25(6). 3173–3173. 3 indexed citations
4.
Royfman, Rachel, et al.. (2023). Contemporary Trends, Characteristics, and Outcomes of Transcatheter Aortic Valve Implantation Among Extreme Elderly Patients. The American Journal of Cardiology. 198. 33–35. 1 indexed citations
5.
Aglan, Amro, et al.. (2023). Sex differences in myocarditis hospitalizations: Rates, outcomes, and hospital characteristics in the National Readmission Database. Current Problems in Cardiology. 49(2). 102233–102233. 1 indexed citations
6.
Changal, Khalid, et al.. (2023). The Efficacy of Cardiac Myosin Inhibitors Versus Placebo in Patients With Symptomatic Hypertrophic Cardiomyopathy: A Meta-Analysis and Systematic Review. The American Journal of Cardiology. 210. 219–224. 7 indexed citations
7.
Royfman, Rachel, et al.. (2023). Clinical Outcomes of Transcatheter Aortic Valve Replacement With and Without Percutaneous Coronary Intervention—An Updated Meta-Analysis and Systematic Review. Current Problems in Cardiology. 48(11). 101980–101980. 3 indexed citations
8.
Changal, Khalid, et al.. (2022). Early surgery or conservative management for asymptomatic severe aortic stenosis: Meta‐analysis of RECOVERY and AVATAR. Journal of Cardiac Surgery. 37(12). 5336–5340. 3 indexed citations
9.
Changal, Khalid, et al.. (2022). Coronary Artery Aneurysms in ST-Elevation Myocardial Infarction (From a United States Based National Cohort). The American Journal of Cardiology. 171. 23–27. 1 indexed citations
10.
Changal, Khalid, Rachel Royfman, Mohammed Mhanna, et al.. (2022). Drug-Eluting Stents Versus Conventional Endovascular Therapies in Symptomatic Infrapopliteal Peripheral Artery Disease: A Meta-analysis. SHILAP Revista de lepidopterología. 1(2). 100024–100024. 8 indexed citations
11.
Saeyeldin, Ayman, et al.. (2022). Short-term Outcomes of Hypertensive Crises in Patients with Orthostatic Hypotension. Current Problems in Cardiology. 48(2). 101455–101455. 1 indexed citations
12.
Royfman, Rachel, et al.. (2021). Adenomatous polyposis coli in cancer and therapeutic implications. Oncology Reviews. 15(1). 534–534. 25 indexed citations
13.
Royfman, Rachel, et al.. (2021). Lack of trusted diagnostic tools for undetermined male infertility. Journal of Assisted Reproduction and Genetics. 38(2). 265–276. 33 indexed citations
14.
Devanaboyina, Monika, et al.. (2021). GM-CSF: Anti-Cancer Immune Response and Therapeutic Application. Journal of Vaccines & Vaccination. 2–13. 1 indexed citations
15.
Royfman, Rachel, Susan Morand, Justin F. Creeden, et al.. (2021). BRCA1/2 Signaling and Homologous Recombination Deficiency in Breast and Ovarian Cancer. Future Oncology. 17(21). 2817–2830. 10 indexed citations
16.
Royfman, Rachel, et al.. (2020). Sterility, an Overlooked Health Condition. MDPI (MDPI AG). 1(1). 29–45. 4 indexed citations
17.
Morand, Susan, Rachel Royfman, Monika Devanaboyina, et al.. (2020). Current Ovarian Cancer Maintenance Strategies and Promising New Developments. Journal of Cancer. 12(1). 38–53. 47 indexed citations
18.
Ashraf, Usman, Ahmed A. Abokor, Rachel Royfman, et al.. (2020). SARS-CoV-2, ACE2 expression, and systemic organ invasion. Physiological Genomics. 53(2). 51–60. 103 indexed citations
19.
Fishman, Emily, Dong Kong, Rachel Royfman, et al.. (2018). A novel atypical sperm centriole is functional during human fertilization. Nature Communications. 9(1). 2210–2210. 92 indexed citations
20.
Fishman, Emily, et al.. (2017). Atypical centrioles are present in Tribolium sperm. Open Biology. 7(3). 160334–160334. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nathalie Da Silva Breakdown of academic impact, for papers by Kyra Minahan Breakdown of academic impact, for papers by Mira Mousa Breakdown of academic impact, for papers by Andrea Mathe Breakdown of academic impact, for papers by Songyang Yuan Breakdown of academic impact, for papers by Ruiqin Han Breakdown of academic impact, for papers by Tiantian Li Breakdown of academic impact, for papers by Amal F. Alshammary Breakdown of academic impact, for papers by Yile Zhang
Rankless by CCL
2026